An autoradiographic study on an array of human breast cancer tissues showed that the antagonist [177Lu]DOTABASS had greater binding affinity to SSTR2 in comparison with the established agonist radioligand [177Lu]DOTATATE [72]. Here, SSTR2 is linked to breast cancer.